Sara (@sarajorndoff) 's Twitter Profile
Sara

@sarajorndoff

Christ Follower ✝️, Girl Mom ♥️, Trophy Wife 🙋🏼‍♀️, Oncology Nurse 💉, Do More Mindset 💪🏻 . My views are my own.

ID: 2721270761

calendar_today23-07-2014 00:55:52

10 Tweet

32 Followers

353 Following

Syndax (@syndax) 's Twitter Profile Photo

#NewsAlert: Today, we shared positive topline results from the R/R mNPM1 acute myeloid leukemia (#AML) cohort in the pivotal Phase 2 portion of the AUGMENT-101 trial of revumenib. These data underscore the long-term potential of revumenib, which has shown compelling results in

#NewsAlert: Today, we shared positive topline results from the R/R mNPM1 acute myeloid leukemia (#AML) cohort in the pivotal Phase 2 portion of the AUGMENT-101 trial of revumenib.

These data underscore the long-term potential of revumenib, which has shown compelling results in
Syndax (@syndax) 's Twitter Profile Photo

#NewsAlert: We are thrilled to announce a major milestone for Syndax. The U.S. Food and Drug Administration (FDA) has now approved the first and only therapy for relapsed or refractory acute leukemia with a KMT2A translocation. We would like to extend our heartfelt gratitude to

#NewsAlert: We are thrilled to announce a major milestone for Syndax. The U.S. Food and Drug Administration (FDA) has now approved the first and only therapy for relapsed or refractory acute leukemia with a KMT2A translocation.

We would like to extend our heartfelt gratitude to